Dietary trans-vaccenic acid enhances anti-tumor immunity
膳食反式牛油酸增强抗肿瘤免疫力
基本信息
- 批准号:10562449
- 负责人:
- 金额:$ 37.52万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-12-07 至 2027-11-30
- 项目状态:未结题
- 来源:
- 关键词:AcetoacetatesAcidsAdultAgonistAntibodiesApoptosisAttenuatedBRAF geneBindingBinding ProteinsBloodBreast Cancer CellButterCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCancer PatientCell ProliferationCell SurvivalChemicalsChondroitin SulfatesClinicalColon CarcinomaCyclic AMPCyclic AMP-Dependent Protein KinasesCyclic AMP-Responsive DNA-Binding ProteinDNA sequencingDairy ProductsDataDietDietary ProteinsEatingElementsEnhancersEpigenetic ProcessExhibitsFFAR2 geneFoundationsG-Protein-Coupled ReceptorsGenetic TranscriptionHippophaeHumanHuman MilkImmuneImmune checkpoint inhibitorImmune responseImmunologicsImmunotherapyIn VitroKetone BodiesKnockout MiceLewis lung carcinoma cellLibrariesLinkLipidsMC38Malignant NeoplasmsMilkMusNude MiceNutrientNutrition TherapyOilsOutcomePD-1/PD-L1Pathway interactionsPeriodicityPopulationRecoveryResearch ActivitySignal TransductionSignaling MoleculeSingle-Stranded DNAStereoisomerStructureT-Cell ActivationT-Cell ProliferationT-LymphocyteTestingTrans Fatty AcidsTumor ImmunityTumor-Infiltrating LymphocytesVolatile Fatty AcidsWorkXenograft procedurecancer infiltrating T cellscancer initiationcancer riskcancer therapycheckpoint therapychemotherapydesigndiet and cancerdietarydietary supplementsexhaustionextracellularimmunodeficient mouse modelimmunogenicimprovedinsightinterestkethoxallung cancer cellmelanomametermultidisciplinarynext generation sequencingnovelprogrammed cell death ligand 1programmed cell death protein 1responsetranscriptometranscriptome sequencingtreatment responsetumortumor growth
项目摘要
Project Summary/Abstract:
Despite extensive studies on relationships between diets and cancer risk, or many “balanced” nutrition therapies
with hope to keep cancer patients healthy and strong for treatment and recovery, little is known about how dietary
substances influence cancer. Our recent work supports a novel concept that acetoacetate, a diet-derived,
circulating ketone body, and chondroitin sulfate, a dietary supplement, function as signaling molecules and
selectively promote BRAF V600E-expressing tumor growth. This lays the foundation for our central question
that is: which circulating diet-derived substances - defined as “blood chemicals”, commonly containing diet-
derived nutrients including inorganics, organic metabolites, lipids, dietary supplements and proteins - potentiate
or attenuate cancer initiation, progression or responses to anti-cancer therapies, and how? We thus constructed
a “blood chemical (BC)” compound library and performed two preliminary screens to identify BCs that influence
responses to immune checkpoint inhibitors (ICIs). We identified trans-vaccenic acid (TVA; a.k.a. (11E)-octadec-
11-enoic acid) as an “overlapping” top candidate from both screens, which not only enhances activation of T
cells but also “rescues” PD-L1/PD-1-dependent exhaustion of T cells. TVA is the predominant form of trans-
fatty acids enriched in human milk, while cis-vaccenic acid (CVA), a stereoisomer of TVA, is found in Sea
Buckthorn oil. TVA is also commonly found in dairy products including milk and butter. TVA is relatively stable,
and naturally only ~19% or 12% of dietary TVA is converted to rumenic acid in human or mice, respectively.
Using diverse immunogenic and immunodeficient mouse models, we found that TVA, but not CVA, enhances
anti-tumor immunity via CD8+ T cells. Mechanistically, TVA exhibits extracellular signaling function and
enhances CD8+ T cell activation through a G-protein-coupled receptor (GPCR)-cAMP-responsive element
binding protein (CREB) pathway. Moreover, we identified immunosuppressive GPR43, a short chain fatty acid
(SCFA)-binding GPCR, as a target of TVA. Taken together, we hypothesize that dietary TVA functions as a
signaling molecule to potentiate activation of CD8+ T cells by attenuating GPR43, leading to enhanced anti-tumor
immunity. Thus, TVA’s effects on T cells are independent of the PD-L1/PD1 axis, providing a perfect rationale to
evaluate potentially synergistic efficacy of TVA in combination with immune checkpoint therapy for an improved
immunotherapy. Three specific aims include: (1) To test the hypothesis that dietary TVA enhances CD8+ T cell
activity and consequent anti-tumor immunity as a single agent, and has synergistic effects in combination with
ICIs; (2) To test the hypothesis that dietary TVA exhibits extracellular signaling function through a GPCR-CREB
axis for CD8+ T cell activation, and explore the underlying signaling and epigenetic mechanisms by temporal,
integrated mechanistic studies; and (3) To test the hypothesis that TVA attenuates GPR43 by competing with its
SCFA agonists, and perform structure-activity research (SAR) to design TVA-derivatives with improved efficacy
to target GPR43 and consequently activate CD8+ T cells.
项目概要/摘要:
尽管有大量关于饮食和癌症风险之间关系的研究,或许多“平衡”营养疗法,
为了让癌症患者在治疗和康复过程中保持健康和强壮,人们对饮食如何影响癌症的治疗和康复知之甚少。
物质影响癌症。我们最近的工作支持了一个新的概念,乙酰乙酸,一种饮食衍生的,
循环酮体和膳食补充剂硫酸软骨素作为信号分子发挥作用,
选择性促进表达BRAF V600 E的肿瘤生长。这为我们的中心问题奠定了基础
即:循环的饮食衍生物质-定义为“血液化学物质”,通常含有饮食-
衍生营养素,包括无机物、有机代谢物、脂质、膳食补充剂和蛋白质-增强
或减弱癌症的发生、进展或对抗癌治疗的反应,以及如何做到这一点?因此,我们构建了
“血液化学(BC)”化合物库,并进行了两次初步筛选,以确定影响
免疫检查点抑制剂(ICI)。我们鉴定了反式异油酸(TVA; a.k.a.(11 E)-十八碳-
11-烯酸)作为来自两种筛选的“重叠”最佳候选物,其不仅增强T
细胞,而且还“拯救”T细胞的PD-L1/PD-1依赖性耗竭。TVA是反式-
人乳中富含的脂肪酸,而顺式异油酸(CVA),TVA的立体异构体,在海中发现
沙棘油。TVA也常见于乳制品,包括牛奶和黄油。TVA相对稳定,
在人或小鼠中,天然地分别只有约19%或12%的膳食TVA转化为瘤胃酸。
使用不同的免疫原性和免疫缺陷小鼠模型,我们发现TVA,而不是CVA,
通过CD 8 + T细胞的抗肿瘤免疫。在机制上,TVA表现出细胞外信号传导功能,
通过G蛋白偶联受体(GPCR)-cAMP反应元件增强CD 8 + T细胞活化
结合蛋白(CREB)途径。此外,我们还鉴定出了免疫抑制性GPR 43,一种短链脂肪酸
(SCFA)结合GPCR作为TVA的靶标。综上所述,我们假设饮食中的TVA起着
通过减弱GPR 43来增强CD 8 + T细胞的活化,导致增强的抗肿瘤作用。
免疫力因此,TVA对T细胞的作用不依赖于PD-L1/PD 1轴,这为TVA的治疗提供了完美的理论基础。
评估TVA与免疫检查点疗法联合用于改善
免疫疗法三个具体的目的包括:(1)验证膳食TVA促进CD 8 + T细胞增殖的假设
活性和随之产生的抗肿瘤免疫力,并且与
(2)验证膳食TVA通过GPCR-CREB发挥细胞外信号传导功能的假设
轴的CD 8 + T细胞活化,并探讨潜在的信号转导和表观遗传机制,
综合机制研究;和(3)为了验证TVA通过与其竞争而减弱GPR 43的假设,
SCFA激动剂,并进行结构活性研究(SAR),以设计具有改善功效的TVA衍生物
靶向GPR 43,从而激活CD 8 + T细胞。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jing Chen其他文献
Porous nanocubic Mn3O4–Co3O4 composites and their application as electrochemical supercapacitors†
- DOI:
- 发表时间:
2012 - 期刊:
- 影响因子:
- 作者:
Huan Pang;Jiawei Li;Jimin Du;Sujuan Li;Juan LI;Yahui Ma,;Jiangshan Zhang;Jing Chen; - 通讯作者:
Jing Chen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jing Chen', 18)}}的其他基金
The role of EMT transcription factor Zeb2 in fetal hematopoiesis
EMT转录因子Zeb2在胎儿造血中的作用
- 批准号:
10604587 - 财政年份:2023
- 资助金额:
$ 37.52万 - 项目类别:
Oxidative pentose phosphate pathway regulates AMPK
氧化戊糖磷酸途径调节 AMPK
- 批准号:
10381359 - 财政年份:2021
- 资助金额:
$ 37.52万 - 项目类别:
Mathematical modeling of spatiotemporal and mechanical processes in cellular functions
细胞功能时空和机械过程的数学建模
- 批准号:
10471262 - 财政年份:2020
- 资助金额:
$ 37.52万 - 项目类别:
Mathematical modeling of spatiotemporal and mechanical processes in cellular functions
细胞功能时空和机械过程的数学建模
- 批准号:
10028816 - 财政年份:2020
- 资助金额:
$ 37.52万 - 项目类别:
Mathematical modeling of spatiotemporal and mechanical processes in cellular functions
细胞功能时空和机械过程的数学建模
- 批准号:
10237345 - 财政年份:2020
- 资助金额:
$ 37.52万 - 项目类别:
Oxidative pentose phosphate pathway regulates AMPK homeostasis by balancing opposing LKB1 and PP2A
氧化戊糖磷酸途径通过平衡 LKB1 和 PP2A 来调节 AMPK 稳态
- 批准号:
10305369 - 财政年份:2014
- 资助金额:
$ 37.52万 - 项目类别:
Signaling and Targeting of 6-Phosphogluconate Dehydrogenase in Human Cancers
人类癌症中 6-磷酸葡萄糖酸脱氢酶的信号传导和靶向
- 批准号:
9000567 - 财政年份:2014
- 资助金额:
$ 37.52万 - 项目类别:
Oxidative pentose phosphate pathway regulates AMPK homeostasis by balancing opposing LKB1 and PP2A
氧化戊糖磷酸途径通过平衡 LKB1 和 PP2A 来调节 AMPK 稳态
- 批准号:
10580662 - 财政年份:2014
- 资助金额:
$ 37.52万 - 项目类别:
Oxidative pentose phosphate pathway regulates AMPK homeostasis by balancing opposing LKB1 and PP2A
氧化戊糖磷酸途径通过平衡 LKB1 和 PP2A 来调节 AMPK 稳态
- 批准号:
10524081 - 财政年份:2014
- 资助金额:
$ 37.52万 - 项目类别:
Signaling and Targeting of 6-Phosphogluconate Dehydrogenase in Human Cancers
人类癌症中 6-磷酸葡萄糖酸脱氢酶的信号传导和靶向
- 批准号:
8630691 - 财政年份:2014
- 资助金额:
$ 37.52万 - 项目类别:
相似国自然基金
具有抗癌活性的天然产物金霉酸(Aureolic acids)全合成与选择性构建2-脱氧糖苷键
- 批准号:22007039
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
海洋放线菌来源聚酮类化合物Pteridic acids生物合成机制研究
- 批准号:
- 批准年份:2019
- 资助金额:10.0 万元
- 项目类别:省市级项目
手性Lewis Acids催化的分子内串联1,5-氢迁移/环合反应及其在构建结构多样性手性含氮杂环化合物中的应用
- 批准号:21372217
- 批准年份:2013
- 资助金额:80.0 万元
- 项目类别:面上项目
对空气稳定的新型的有机金属Lewis Acids催化剂制备、表征与应用研究
- 批准号:21172061
- 批准年份:2011
- 资助金额:30.0 万元
- 项目类别:面上项目
钛及含钛Lewis acids促臭氧/过氧化氢体系氧化性能的广普性、高效性及其机制
- 批准号:21176225
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
基于Zip Nucleic Acids引物对高度降解和低拷贝DNA检材的STR分型研究
- 批准号:81072511
- 批准年份:2010
- 资助金额:31.0 万元
- 项目类别:面上项目
海洋天然产物Makaluvic acids 的全合成及其对南海鱼虱存活的影响
- 批准号:30660215
- 批准年份:2006
- 资助金额:21.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Lipid nanoparticle-mediated Inhalation delivery of anti-viral nucleic acids
脂质纳米颗粒介导的抗病毒核酸的吸入递送
- 批准号:
502577 - 财政年份:2024
- 资助金额:
$ 37.52万 - 项目类别:
CAREER: Highly Rapid and Sensitive Nanomechanoelectrical Detection of Nucleic Acids
职业:高度快速、灵敏的核酸纳米机电检测
- 批准号:
2338857 - 财政年份:2024
- 资助金额:
$ 37.52万 - 项目类别:
Continuing Grant
Double Incorporation of Non-Canonical Amino Acids in an Animal and its Application for Precise and Independent Optical Control of Two Target Genes
动物体内非规范氨基酸的双重掺入及其在两个靶基因精确独立光学控制中的应用
- 批准号:
BB/Y006380/1 - 财政年份:2024
- 资助金额:
$ 37.52万 - 项目类别:
Research Grant
Quantifying L-amino acids in Ryugu to constrain the source of L-amino acids in life on Earth
量化 Ryugu 中的 L-氨基酸以限制地球生命中 L-氨基酸的来源
- 批准号:
24K17112 - 财政年份:2024
- 资助金额:
$ 37.52万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Synthetic analogues based on metabolites of omega-3 fatty acids protect mitochondria in aging hearts
基于 omega-3 脂肪酸代谢物的合成类似物可保护衰老心脏中的线粒体
- 批准号:
477891 - 财政年份:2023
- 资助金额:
$ 37.52万 - 项目类别:
Operating Grants
Metabolomic profiles of responders and non-responders to an omega-3 fatty acids supplementation.
对 omega-3 脂肪酸补充剂有反应和无反应者的代谢组学特征。
- 批准号:
495594 - 财政年份:2023
- 资助金额:
$ 37.52万 - 项目类别:
Molecular recognition and enantioselective reaction of amino acids
氨基酸的分子识别和对映选择性反应
- 批准号:
23K04668 - 财政年份:2023
- 资助金额:
$ 37.52万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Integrated understanding and manipulation of hypoxic cellular functions by artificial nucleic acids with hypoxia-accumulating properties
具有缺氧累积特性的人工核酸对缺氧细胞功能的综合理解和操纵
- 批准号:
23H02086 - 财政年份:2023
- 资助金额:
$ 37.52万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Basic research toward therapeutic strategies for stress-induced chronic pain with non-natural amino acids
非天然氨基酸治疗应激性慢性疼痛策略的基础研究
- 批准号:
23K06918 - 财政年份:2023
- 资助金额:
$ 37.52万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanisms how arrestins that modulate localization of glucose transporters are phosphorylated in response to amino acids
调节葡萄糖转运蛋白定位的抑制蛋白如何响应氨基酸而被磷酸化的分子机制
- 批准号:
23K05758 - 财政年份:2023
- 资助金额:
$ 37.52万 - 项目类别:
Grant-in-Aid for Scientific Research (C)